Immune modulation in xenotransplantation

Area of Science:

• Immunology
• Transplantation Biology
• Genetic Engineering

Background:

• The growing demand for human organs for transplantation necessitates alternative sources.
• Xenotransplantation, using animal organs, is a potential solution, with pigs being the most suitable donors.
• Significant immunological barriers exist between humans and pigs, hindering xenotransplantation success.

Purpose of the Study:

• To outline strategies for genetically modifying pigs to overcome immunological challenges in xenotransplantation.
• To reduce xenograft immunogenicity and prevent hyperacute and delayed rejection.
• To explore the potential of producing multitransgenic pigs for successful organ transplantation in humans.

Main Methods:

• Genetic engineering techniques to modify the porcine genome.
• Incorporation of human genes to regulate complement pathways.
• Knockout of the gene for Gal antigen (α1,3-galactosyltransferase) and modification of surface proteins.
• Inhibition of cell-mediated rejection by targeting natural killer cells and macrophages.
• Addressing coagulation system incompatibilities to maintain hemostasis.

Main Results:

• Genetic modifications can reduce the immunogenicity of porcine organs.
• Targeting complement and coagulation pathways is crucial for xenograft survival.
• Simultaneous genetic modifications are necessary to overcome multiple rejection mechanisms.

Conclusions:

• Multitransgenic pigs hold promise for overcoming immunological barriers in xenotransplantation.
• Genetic engineering offers a viable approach to create organs suitable for human recipients.
• Successful xenotransplantation requires a comprehensive strategy addressing both cellular and humoral immune responses.